ARMISTICE CAPITAL, LLC Quant / Systematic

Location: New York, NY

CIK: 0001601086 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value: $263M (98.2% shares, 1.8% debt)

Holdings (46)

SPDR S&P 500 ETF TR 14.4%
Value $37.71M Shares 180,000 Est. Cost Unrealized
ANTARES PHARMA INC 6.2%
Value $16.2M Shares 15,430,000 Est. Cost $1.72 Unrealized
VNDA VANDA PHARMACEUTICALS INC 3.4%
Value $8.952M Shares 800,000 Est. Cost $10.67 Unrealized -9.3%
ARALEZ PHARMACEUTICALS INC 3.3%
Value $8.791M Shares 2,664,000 Est. Cost $3.30 Unrealized
TAILORED BRANDS INC 3.3%
Value $8.71M Shares 688,000 Est. Cost $15.71 Unrealized
IGNYTA INC 3.2%
Value $8.434M Shares 1,556,000 Est. Cost $7.20 Unrealized
SGI TEMPUR SEALY INTL INC 3.0%
Value $7.966M Shares 144,000 Est. Cost $14.75 Unrealized 0.0%
BUFFALO WILD WINGS INC 3.0%
Value $7.781M Shares 56,000 Est. Cost $144.19 Unrealized
HAIN HAIN CELESTIAL GROUP INC 2.9%
Value $7.562M Shares 152,000 Est. Cost $45.35 Unrealized +2.1%
HAIN CELESTIAL GROUP INC 2.8%
Value $7.463M Shares 150,000 Est. Cost Unrealized
LVS LAS VEGAS SANDS CORP 2.7%
Value $7.132M Shares 164,000 Est. Cost $35.61 Unrealized +2.6%
FRPT FRESHPET INC 2.7%
Value $6.998M Shares 750,000 Est. Cost $12.51 Unrealized -31.0%
HORIZON PHARMA PLC 2.5%
Value $6.588M Shares 400,000 Est. Cost $16.47 Unrealized
NOMD NOMAD HLDGS LTD 2.4%
Value $6.384M Shares 800,000 Est. Cost $8.84 Unrealized -0.3%
THC TENET HEALTHCARE CORP 2.4%
Value $6.302M Shares 228,000 Est. Cost $29.55 Unrealized 0.0%
BIODELIVERY SCIENCES 2.4%
Value $6.259M Shares 2,652,000 Est. Cost $5.51 Unrealized
ACORDA THERAPEUTICS INC 2.3%
Value $5.917M Shares 232,000 Est. Cost $28.35 Unrealized
SNY SANOFI 2.2%
Value $5.775M Shares 138,000 Est. Cost $41.85 Unrealized
DECK DECKERS OUTDOOR CORP 2.2%
Value $5.752M Shares 100,000 Est. Cost $10.02 Unrealized -7.8%
KATE SPADE & CO 2.0%
Value $5.317M Shares 258,000 Est. Cost $18.14 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 2.0%
Value $5.292M Shares 240,000 Est. Cost $26.18 Unrealized 0.0%
BLUCORA INC 2.0%
Value $5.18M Shares 500,000 Est. Cost $8.77 Unrealized
SYNERGY PHARMACEUTICALS DEL 1.9%
Value $5.054M Shares 1,330,000 Est. Cost $2.76 Unrealized
PERNIX THERAPEUTICS HLDGS IN 1.8%
Value $4.834M Shares 22,760,000 Est. Cost $0.21 Unrealized
VALEANT PHARMACEUTICALS INTL 1.8%
Value $4.834M Shares 240,000 Est. Cost Unrealized
TTWO TAKE-TWO INTERACTIVE SOFTWAR 1.7%
Value $4.55M Shares 120,000 Est. Cost $34.63 Unrealized +6.4%
BLUEBIRD BIO INC 1.6%
Value $4.156M Shares 96,000 Est. Cost $43.29 Unrealized
BLUE NILE INC 1.5%
Value $4.052M Shares 148,000 Est. Cost $27.38 Unrealized
PZZA PAPA JOHNS INTL INC 1.5%
Value $3.944M Shares 58,000 Est. Cost $49.58 Unrealized 0.0%
DEL FRISCOS RESTAURANT GROUP 1.5%
Value $3.895M Shares 272,000 Est. Cost $14.32 Unrealized
HABIT RESTAURANTS INC 1.5%
Value $3.866M Shares 236,000 Est. Cost $16.38 Unrealized
FLAMEL TECHNOLOGIES SA 1.4%
Value $3.738M Shares 348,003 Est. Cost $10.74 Unrealized
DEMAND MEDIA INC 1.4%
Value $3.722M Shares 720,000 Est. Cost $5.57 Unrealized
RESTORATION HARDWARE HLDGS I 1.4%
Value $3.671M Shares 128,000 Est. Cost $28.68 Unrealized
RRR RED ROCK RESORTS INC 1.3%
Value $3.473M Shares 158,000 Est. Cost $20.38 Unrealized 0.0%
L BRANDS INC 1.3%
Value $3.357M Shares 50,000 Est. Cost $67.14 Unrealized
TENAX THERAPEUTICS INC 1.1%
Value $2.842M Shares 1,110,000 Est. Cost $3.07 Unrealized
TETRAPHASE PHARMACEUTICALS I 0.8%
Value $2.073M Shares 482,073 Est. Cost $4.30 Unrealized
QLT INC 0.6%
Value $1.556M Shares 1,095,455 Est. Cost $1.42 Unrealized
SCYNEXIS INC 0.6%
Value $1.515M Shares 698,000 Est. Cost $2.17 Unrealized
ABUS ARBUTUS BIOPHARMA CORP 0.5%
Value $1.42M Shares 408,000 Est. Cost $4.23 Unrealized 0.0%
LIPOCINE INC NEW 0.5%
Value $1.216M Shares 400,000 Est. Cost $3.04 Unrealized
AEGERION PHARMACEUTICALS INC 0.5%
Value $1.192M Shares 800,000 Est. Cost $8.84 Unrealized
MEDIGUS LTD 0.2%
Value $625K Shares 618,600 Est. Cost $4.41 Unrealized
OFFICE DEPOT INC 0.2%
Value $463K Shares 139,900 Est. Cost Unrealized
SYNTA PHARMACEUTICALS CORP 0.1%
Value $156K Shares 600,000 Est. Cost $0.26 Unrealized